BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3587721)

  • 1. [Long-term results of the peritoneovenous shunt in the treatment of intractable ascites in cirrhotic patients].
    Dellepiane M; Capussotti L; Polastri R; Mensa G; Marucci MM; Fusario F
    Minerva Med; 1987 May; 78(10):717-20. PubMed ID: 3587721
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peritoneovenous shunting in intractable ascites of cirrhosis. Results of a prospective study on improving prognostic factors].
    Hillaire S; Labianca M; Smadja C; Grange D; Franco D
    Gastroenterol Clin Biol; 1988 Oct; 12(10):681-6. PubMed ID: 3220223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Irreducible ascites in cirrhotic patients. Results of peritoneo-jugular shunt in 16 patients (author's transl)].
    Paliard P; Partensky C; Saubier E
    Nouv Presse Med; 1981 Sep; 10(33):2715-8. PubMed ID: 6974851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneovenous shunts in patients with intractable ascites: palliation at what price?
    Zervos EE; McCormick J; Goode SE; Rosemurgy AS
    Am Surg; 1997 Feb; 63(2):157-62. PubMed ID: 9012430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peritoneo-jugular shunt for intractable ascites in cirrhosis: 88 cases (author's transl)].
    Franco D; Cortesse A; Castro e Sousa F; Bismuth H
    Gastroenterol Clin Biol; 1981 Apr; 5(4):393-402. PubMed ID: 7227747
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
    Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
    Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneovenous shunting for intractable ascites.
    Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation].
    Mabrut JY; de la Roche E; Adham M; Ducerf C; Baulieux J
    Ann Chir; 1998; 52(7):612-7. PubMed ID: 9805798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of peritoneal port-systems in the treatment of diuretic-resistant cirrhotic ascites].
    Abdurakhmanov BA; Gantsev ShKh; Kulakeev OK
    Khirurgiia (Mosk); 2010; (4):30-3. PubMed ID: 20517235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Denver peritoneojugular shunt. Current indications].
    Bracci F; Bracaglia C; Zampino MA; Farina F; Cucchiara G
    Minerva Med; 1989 Apr; 80(4):363-6. PubMed ID: 2725937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
    Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
    Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peritoneojugular shunt for intractable ascites in cirrhotic patients : evaluation of 25 patients].
    Toumieux B
    Gastroenterol Clin Biol; 1982 Dec; 6(12):978-82. PubMed ID: 7160595
    [No Abstract]   [Full Text] [Related]  

  • 15. [Surgical treatment of refractory ascites with peritoneovenous shunt and its complications].
    Brescia A; La Torre F; Pieralisi G
    Ann Ital Chir; 1983; 55(4):385-93. PubMed ID: 6673622
    [No Abstract]   [Full Text] [Related]  

  • 16. Long term results (greater than 5 years) in patients with peritoneovenous shunting for intractable ascites: liver function and cancer mortality.
    Franco D; Meakins JL; Wu A; Smadja C; Bonnet P; Gouffier E; Campillo B
    HPB Surg; 1989 Oct; 1(3):185-91, discussion 191-4. PubMed ID: 2487384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment of the ascitic patient using LeVeen peritoneojugular shunt. Personal case reports].
    Amerio A; Giudici Cipriani A; Cananzi C; Zanelli G; Zinicola N
    Minerva Chir; 1986 Feb; 41(3-4):125-33. PubMed ID: 3515230
    [No Abstract]   [Full Text] [Related]  

  • 18. [12-year experience with continuous peritoneovenous shunt in the treatment of therapy-resistant ascites and hepatorenal failure: benefits and pitfalls].
    Kreuzer W
    Wien Klin Wochenschr; 1989 Jan; 101(2):87-91. PubMed ID: 2916345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LeVeen peritoneo-venous shunt in treatment of intractable cirrhotic ascites.
    Chen YR; Chen MZ
    Chin Med J (Engl); 1984 May; 97(5):376-8. PubMed ID: 6439491
    [No Abstract]   [Full Text] [Related]  

  • 20. Are mechanical shunting options viable for the management of intractable ascites?
    Rector WG
    Am J Gastroenterol; 1988 Oct; 83(10):1085. PubMed ID: 3421216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.